Old Web
English
Sign In
Acemap
>
authorDetail
>
Charlotte Vignal
Charlotte Vignal
Hoffmann-La Roche
Medicine
Immunology
Diffuse large B-cell lymphoma
Obinutuzumab
CHOP
3
Papers
26
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Trial in Progress: The Phase III, Randomized, Open-Label, Multicenter COMMODORE 1 Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Adult and Adolescent Patients with Paroxysmal Nocturnal Hemoglobinuria Currently Treated with Complement Inhibitors
2020
Blood
Antonio M. Risitano
Alexander Röth
Austin G. Kulasekararaj
Jeffrey Pu
Junichi Nishimura
Lilyan Wright
Anita Appius
Alexandre Sostelly
Sasha Sreckovic
Charlotte Vignal
Talha Munir
Show All
Source
Cite
Save
Citations (1)
Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study
2019
Leukemia & Lymphoma
Jeff P. Sharman
Andres Forero-Torres
Luciano J. Costa
Ian W. Flinn
Lowell Inhorn
Kevin Kelly
Alberto Bessudo
Luis Fayad
Mark S. Kaminski
Andrew M. Evens
Christopher R. Flowers
Deniz Sahin
Kirsten Mundt
Thomas Sandmann
Günter Fingerle-Rowson
Charlotte Vignal
Mehrdad Mobasher
Andrew D. Zelenetz
Show All
Source
Cite
Save
Citations (6)
Safety and Efficacy Of Obinutuzumab (GA101) Plus CHOP Chemotherapy In First-Line Advanced Diffuse Large B-Cell Lymphoma: Results From The Phase 2 Gather Study (GAO4915g)
2013
Blood
Andrew D. Zelenetz
Mehrdad Mobasher
Luciano J. Costa
Ian W. Flinn
Christopher R. Flowers
Mark S. Kaminski
Thomas Sandmann
Kerstin Trunzer
Charlotte Vignal
Andres Forero-Torres
Show All
Source
Cite
Save
Citations (19)
1